Marathon Asset Management LP is a global alternative investment and asset management company with approximately $11 billion in capital
Marathon Asset Management LP is a global alternative investment and asset management company with approximately $11 billion in capital under management. Marathon's core businesses include hedge funds, structured finance, emerging markets, and real estate. Founded in 1998, the firm has 130 professionals worldwide with headquarters in New York City and investment offices in London and Singapore.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 7, 2022
Acer Therapeutics
|
Post-IPO Debt | $48.50M | Biotechnology | — |
Jun 1, 2020
Baudax Bio
|
Post-IPO Debt | $50M | Biotechnology | Yes |
Oct 11, 2017
ADMA Biologics
|
Post-IPO Debt | $30M | Biotechnology | Yes |